Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Two Novel Tri-Aryl Derivatives Attenuate the Invasion-Promoting Effects of Stromal Mesenchymal Stem Cells on Breast Cancer Publisher Pubmed



Moradi K1, 5 ; Barneh F2, 5 ; Irian S1 ; Amini M3 ; Moradpoor R2 ; Amanzadeh A4 ; Choopani S5 ; Rahimi H6 ; Ghodselahi T7 ; Boujar MM1 ; Salimi M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
  2. 2. Department of Basic Sciences, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Medicinal Chemistry Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran
  5. 5. Physiology and Pharmacology Department, Pasteur Institute of Iran, Tehran, Iran
  6. 6. Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
  7. 7. Nano Mabna Iranian Inc, P.O. Box 1676664116, Tehran, Iran

Source: Anti-Cancer Agents in Medicinal Chemistry Published:2019


Abstract

Background: The concept of Epithelial-Mesenchymal Transition (EMT) to promote carcinoma progression has been recognized as a venue for research on novel anticancer drugs. Triaryl template-based structures are one of the pivotal structural features found in a number of compounds with a wide variety of biological properties including anti-breast cancer. Among the various factors triggering EMT program, cyclooxygenase-2 (COX-2), NF-κB as well as the transforming growth factor-beta (TGF-Β) have been widely investigated. Objective: Here, we aim to investigate the effect of two novel compounds A and B possessing triaryl structures, which interact with both COX-2 and TGF-Β active sites and suppress NF-κB activation, on EMT in a co-culture system with breast cancer and stromal cells. Methods: MDA-MB-231 and bone-marrow mesenchymal stem (BM-MS) cells were co-cultured in a trans-well plate. Migration, matrigel-based invasion and colony formation in soft agar assays along with Real- time PCR and Western blot analysis were performed to examine the effect of compounds A and B on the invasive properties of MDA-MB-231 cells after 72 hours of co-culturing with BM-MSCs. In addition, TGF-beta interaction was investigated by Localized Surface Plasmon Resonance (LSPR). Results: BM-MSCs enhanced migration, invasion and anchorage-independent growth of the co-cultured MDAMB- 231 cells. A reduction in E-cadherin level concomitant with an increase in vimentin and N-cadherin levels following the co-culture implied EMT as the underlying process. Compounds A and B inhibited invasion and anchorage-independent growth of breast cancer cells co-cultured with BM-MSCs at 10µM. The observed inhibitory effects along with an increase in E-cadherin and a reduction in vimentin and ZEB2 levels suggest that the anti-invasive properties of compounds A and B might proceed through the blockade of stromal cell-induced EMT, mediated by their interaction with TGF-beta. Conclusion: These findings introduce compounds A and B as novel promising agents, which prevent EMT in invasive breast cancer cells. © 2019 Bentham Science Publishers.